Dr Saurabh Malhotra, MD | |
2800 Main St Dept Of, Bridgeport, CT 06606-4201 | |
(203) 576-5033 | |
Not Available |
Full Name | Dr Saurabh Malhotra |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 2800 Main St Dept Of, Bridgeport, Connecticut |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437314648 | NPI | - | NPPES |
PENDING | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZH0000X | Pathology - Hematology | 0101257182 (Virginia) | Secondary |
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 0101257182 (Virginia) | Primary |
Entity Name | Westchester Medical Center Advanced Physician Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912131392 PECOS PAC ID: 3173660776 Enrollment ID: O20091031000042 |
News Archive
New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields - called Tumor-Treating Fields (TTFields) - more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor.
Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs is the potential for tumor growth, or tumorogenesis, post-transplantation.
AIDS Healthcare Foundation (AHF) will host a protest Wednesday morning, February 17 at 8:00am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, the most expensive first-line AIDS treatment in the US, during the 17th Conference of Retroviruses and Opportunistic Infections (CROI) in San Francisco.
Mark Martens, M.D., chief of Obstetrics and Gynecology at Jersey Shore University Medical Center, announces that the hospital is participating in a clinical study to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Saurabh Malhotra, MD 2800 Main St, Vincent's Hospital Dept.of Pathology, Bridgeport, CT 06606-4201 Ph: (203) 576-5033 | Dr Saurabh Malhotra, MD 2800 Main St Dept Of, Bridgeport, CT 06606-4201 Ph: (203) 576-5033 |
News Archive
New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields - called Tumor-Treating Fields (TTFields) - more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor.
Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs is the potential for tumor growth, or tumorogenesis, post-transplantation.
AIDS Healthcare Foundation (AHF) will host a protest Wednesday morning, February 17 at 8:00am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, the most expensive first-line AIDS treatment in the US, during the 17th Conference of Retroviruses and Opportunistic Infections (CROI) in San Francisco.
Mark Martens, M.D., chief of Obstetrics and Gynecology at Jersey Shore University Medical Center, announces that the hospital is participating in a clinical study to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI).
› Verified 7 days ago
Dr. Christine Marianne Minerowicz, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3156 Fax: 203-384-3237 | |
Young Choi Kim, MD Pathology Medicare: Medicare Enrolled Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3157 Fax: 203-384-3237 | |
Dr. George Michael Golenwsky, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 203-576-5033 | |
Dr. Angelique W Levi, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, St. Vincent's Medical Center, Dept. Of Pathology, Bridgeport, CT 06606 Phone: 203-576-5033 | |
Sumi Varghese Thomas, M.B.B.S Pathology Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 732-235-8120 | |
Agedi Nicholson Boto, M.D./PH.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 475-210-5032 Fax: 475-210-5034 |